Document is current
Any future updates will be listed below
-
Authors
Machado, Heather E.
Mitchell, Emily
Øbro, Nina F.
Kübler, Kirsten
Davies, Megan
Leongamornlert, Daniel http://orcid.org/0000-0002-3486-3168
Cull, Alyssa
Maura, Francesco
Sanders, Mathijs A.
Cagan, Alex T. J. http://orcid.org/0000-0002-7857-4771
McDonald, Craig
Belmonte, Miriam
Shepherd, Mairi S.
Vieira Braga, Felipe A.
Osborne, Robert J.
Mahbubani, Krishnaa http://orcid.org/0000-0002-1327-2334
Martincorena, Iñigo http://orcid.org/0000-0003-1122-4416
Laurenti, Elisa http://orcid.org/0000-0002-9917-9092
Green, Anthony R.
Getz, Gad http://orcid.org/0000-0002-0936-0753
Polak, Paz
Saeb-Parsy, Kourosh http://orcid.org/0000-0002-0633-3696
Hodson, Daniel J. http://orcid.org/0000-0001-6225-2033
Kent, David G. http://orcid.org/0000-0001-7871-8811
Campbell, Peter J. http://orcid.org/0000-0002-3921-0510
- License Information
-
More Information
Article History
Received: 20 July 2021
Accepted: 5 July 2022
First Online: 10 August 2022
Competing interests
: G.G. receives research funds from Pharmacyclics and IBM. G.G. is an inventor on multiple patents related to bioinformatics methods (MuTect, MutSig, ABSOLUTE, MSMutSig, MSMuTect, POLYSOLVER and TensorQTL). G.G. is a founder, consultant and holds privately held equity in Scorpion Therapeutics. D.J.H. receives research funding from AstraZeneca and D.G.K. receives research funding from STRM.bio. All other authors declare no competing interests.
